GlaxoSmithKline LLC v. Boehringer Ingelheim Pharm
Plaintiff / Appellee: GLAXOSMITHKLINE LLC
Defendant / Appellant: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Case Number: 20-2926
Filed: September 24, 2020
Court: U.S. Court of Appeals, Third Circuit
Nature of Suit: Other
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on November 20, 2020. A more recent docket listing may be available from PACER.

Date Filed Document Text
November 20, 2020 Opinion or Order Filing 31 ORDER (Clerk) The foregoing Motion by Appellant is referred to the merits panel. The Clerk will hold Volume 3 of the joint appendix provisionally under seal pending a ruling by the Court, filed. (MCW) [Entered: 11/20/2020 04:11 PM]
November 17, 2020 Filing 30 Calendared for Friday, 01/15/2021. Calendar Clerk: CMH. (CMH) [Entered: 11/17/2020 07:35 AM]
November 16, 2020 Opinion or Order Filing 29 ORDER (MATEY, Circuit Judges) granting motion by Appellee for Extension of Time to File Its Brief Until December 1, 2020 with Request to Extend Appellant's Reply Brief Deadline to December 14, 2020. Panel No.: CCO-110. Matey, Authoring Judge. (SLC) [Entered: 11/16/2020 07:10 AM]
November 4, 2020 Filing 28 ECF FILER: UNOPPOSED Motion filed by Appellee GlaxoSmithKline LLC for Extension of Time to file Brief of Appellee until/for 25 days. Certificate of Service dated 11/04/2020. Service made by ECF. [20-2926] (CM) [Entered: 11/04/2020 03:38 PM]
October 15, 2020 Filing 27 HARD COPY RECEIVED from Appellant Boehringer Ingelheim Pharmaceuticals Inc - Appendix. Copies: 4. Volumes: 3 (Volume I attached to Brief; Volume III submitted UNDER SEAL). (MS) [Entered: 10/20/2020 10:45 AM]
October 15, 2020 Filing 26 HARD COPY RECEIVED from Appellant Boehringer Ingelheim Pharmaceuticals Inc - Brief with Volume I of Appendix attached. Copies: 7. (RM) [Entered: 10/15/2020 12:20 PM]
October 13, 2020 Filing 25 ECF FILER: SEALED ELECTRONIC JOINT APPENDIX on behalf of Appellant Boehringer Ingelheim Pharmaceuticals Inc. Certificate of Service dated 10/13/2020 by ECF. [20-2926] (VL) [Entered: 10/13/2020 08:07 PM]
October 13, 2020 Filing 24 ECF FILER: UNOPPOSED Motion filed by Appellant Boehringer Ingelheim Pharmaceuticals Inc to seal Volume III of the Joint Appendix. Certificate of Service dated 10/13/2020. Service made by ECF. [20-2926][SEND TO MERITS PANEL]--[Edited 11/20/2020 by MCW] (VL) [Entered: 10/13/2020 07:51 PM]
October 13, 2020 Filing 23 ECF FILER: ELECTRONIC APPENDIX on behalf of Appellant Boehringer Ingelheim Pharmaceuticals Inc. Certificate of service dated 10/13/2020 by ECF. [20-2926] (VL) [Entered: 10/13/2020 07:30 PM]
October 13, 2020 Filing 22 ECF FILER: ELECTRONIC BRIEF with Volume I of Appendix attached on behalf of Appellant Boehringer Ingelheim Pharmaceuticals Inc. Certificate of Service dated 10/13/2020 by ECF. [20-2926] (VL) [Entered: 10/13/2020 07:15 PM]
October 8, 2020 Filing 21 ECF FILER: Concise Summary of the Case filed by Appellant Boehringer Ingelheim Pharmaceuticals Inc. [20-2926] (KEG) [Entered: 10/08/2020 07:57 PM]
October 8, 2020 Filing 20 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellant Boehringer Ingelheim Pharmaceuticals Inc. [20-2926] (KEG) [Entered: 10/08/2020 07:56 PM]
October 8, 2020 Filing 19 ECF FILER: DISCLOSURE STATEMENT on behalf of Appellee GlaxoSmithKline LLC. [20-2926] (CM) [Entered: 10/08/2020 02:31 PM]
October 8, 2020 Filing 18 ECF FILER: ENTRY OF APPEARANCE from Jane Chong on behalf of Appellee(s) GlaxoSmithKline LLC. [20-2926] (CM) [Entered: 10/08/2020 02:29 PM]
October 8, 2020 Filing 17 ECF FILER: ENTRY OF APPEARANCE from Charles L. McCloud on behalf of Appellee(s) GlaxoSmithKline LLC. [20-2926] (CM) [Entered: 10/08/2020 02:28 PM]
October 8, 2020 Filing 16 ECF FILER: ENTRY OF APPEARANCE from Lisa S. Blatt on behalf of Appellee(s) GlaxoSmithKline LLC. [20-2926] (CM) [Entered: 10/08/2020 02:27 PM]
October 8, 2020 Opinion or Order Filing 15 ORDER (MATEY, Circuit Judge) The foregoing Unopposed Motion to Expedite Appeal with Proposed Briefing Schedule is GRANTED. Panel No.: CCO-123-E. Matey, Authoring Judge. (LMR) [Entered: 10/08/2020 01:25 PM]
October 8, 2020 Filing 14 ECF FILER: ENTRY OF APPEARANCE from Emilia McKee Vassallo on behalf of Appellee(s) GlaxoSmithKline LLC. [20-2926] (MIV) [Entered: 10/08/2020 09:39 AM]
October 8, 2020 Filing 13 ECF FILER: ENTRY OF APPEARANCE from Matthew I. Vahey on behalf of Appellee(s) GlaxoSmithKline LLC. [20-2926] (MIV) [Entered: 10/08/2020 09:37 AM]
October 8, 2020 Filing 12 ECF FILER: ENTRY OF APPEARANCE from Paul Lantieri III on behalf of Appellee(s) GlaxoSmithKline LLC. [20-2926] (MIV) [Entered: 10/08/2020 09:36 AM]
October 8, 2020 Filing 11 ECF FILER: ENTRY OF APPEARANCE from Burt M. Rublin on behalf of Appellee(s) GlaxoSmithKline LLC. [20-2926] (MIV) [Entered: 10/08/2020 09:35 AM]
October 8, 2020 Filing 10 ECF FILER: ENTRY OF APPEARANCE from Stephen J. Kastenberg on behalf of Appellee(s) GlaxoSmithKline LLC. [20-2926] (MIV) [Entered: 10/08/2020 09:34 AM]
October 6, 2020 Filing 9 ECF FILER: Transcript Purchase Order Form (Part 1) filed by Appellant Boehringer Ingelheim Pharmaceuticals Inc advising this court that transcripts are already on file in the District Court. [20-2926] (KEG) [Entered: 10/06/2020 05:14 PM]
October 6, 2020 Filing 8 ECF FILER: CIVIL INFORMATION STATEMENT on behalf of Appellant Boehringer Ingelheim Pharmaceuticals Inc. [20-2926] (KEG) [Entered: 10/06/2020 05:10 PM]
September 25, 2020 Filing 7 ECF FILER: UNOPPOSED Motion filed by Appellant Boehringer Ingelheim Pharmaceuticals Inc to Expedite appeal. Certificate of Service dated 09/25/2020. Service made by Email. [20-2926] (KEG) [Entered: 09/25/2020 10:26 PM]
September 25, 2020 Filing 6 ECF FILER: ENTRY OF APPEARANCE from Vanessa A. Lavely on behalf of Appellant(s) Boehringer Ingelheim Pharmaceuticals Inc.. [20-2926] (VL) [Entered: 09/25/2020 05:33 PM]
September 25, 2020 Filing 5 ECF FILER: ENTRY OF APPEARANCE from Evan R. Chesler on behalf of Appellant(s) Boehringer Ingelheim Pharmaceuticals Inc.. [20-2926] (ERC) [Entered: 09/25/2020 05:30 PM]
September 24, 2020 Filing 4 ECF FILER: ENTRY OF APPEARANCE from Christopher R. Hall, Esquire on behalf of Appellant(s) Boehringer Ingelheim Pharmacueticals, Inc. [20-2926]--[Edited 09/24/2020 by KR] (CRH) [Entered: 09/24/2020 04:09 PM]
September 24, 2020 Filing 3 ECF FILER: ENTRY OF APPEARANCE from Kyle E. Gray, Esquire on behalf of Appellant(s) Boehringer Ingelheim Pharmaceuticals, Inc.. [20-2926]--[Edited 09/24/2020 by KR] (KEG) [Entered: 09/24/2020 03:55 PM]
September 24, 2020 Filing 2 RECORD available on District Court CM/ECF. (SLC) [Entered: 09/24/2020 10:08 AM]
September 24, 2020 Filing 1 CIVIL CASE DOCKETED. Notice filed by Appellant Boehringer Ingelheim Pharmaceuticals Inc in District Court No. 2-19-cv-05321. (SLC) [Entered: 09/24/2020 10:07 AM]

Access additional case information on PACER

Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Search for this case: GlaxoSmithKline LLC v. Boehringer Ingelheim Pharm
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff / appellee: GLAXOSMITHKLINE LLC
Represented By: Matthew I. Vahey Esq.
Represented By: Stephen J. Kastenberg Esq.
Represented By: Paul Lantieri Esq. III
Represented By: Charles McCloud Esq.
Represented By: Lisa S. Blatt Esq.
Represented By: Emelia L. McKee Vassallo Esq.
Represented By: Jane Y. Chong
Represented By: Burt M. Rublin Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant / appellant: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Represented By: Daniel H. Weiner Esq.
Represented By: Christopher R. Hall Esq.
Represented By: Kyle E. Gray Esq.
Represented By: Vanessa Lavely Esq.
Represented By: Evan R. Chesler Esq.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?